| |
| |
|
| Insider
Information: |
Thepaut Eric Francis Yves |
| Relationship: |
EVP & Pres, Eur, Mid-E... |
| City: |
Marlborough |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
31,422 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,374,561 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
31,422 |
|
|
| Total
Value |
$2,374,561 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
4
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
4.0
|
| Percentage
Gain/Loss : |
0.0%
|
 56.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
EVP & Pres, Eur, Mid-E... |
2024-05-10 |
31,422 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
151 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSX |
Boston Scientific Corp |
SVP & Pres, Eur, Mid-East, Afr |
• • – |
2018-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
9,196 |
125,758 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Eur, Mid-East, Afr |
• • – |
2019-02-20 |
4 |
D |
$40.11 |
$433,549 |
D/D |
(10,809) |
120,059 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Pres, Eur, Mid-East, Afr |
• • – |
2021-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,879 |
102,675 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Eur, Mid-East, Afr |
• • – |
2019-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,578 |
112,277 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Pres, Eur, Mid-East, Afr |
• • – |
2024-02-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(11,579) |
26,197 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Eur, Mid-East, Afr |
• • – |
2019-02-27 |
4 |
S |
$39.94 |
$478,520 |
D/D |
(11,980) |
110,169 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Pres, Eur, Mid-East, Afr |
• • – |
2024-05-10 |
4 |
S |
$74.14 |
$958,717 |
D/D |
(12,931) |
31,422 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
EVP & Pres, Eur, Mid-East, Afr |
• • – |
2024-05-10 |
4 |
OE |
$16.31 |
$210,905 |
D/D |
12,931 |
44,353 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Pres, Eur, Mid-East, Afr |
• • – |
2024-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,080 |
25,349 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Pres, Eur, Mid-East, Afr |
• • – |
2022-11-18 |
4 |
S |
$42.72 |
$638,773 |
D/D |
(14,952) |
57,534 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Eur, Mid-East, Afr |
• • – |
2020-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
15,120 |
96,526 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Eur, Mid-East, Afr |
• • – |
2018-11-29 |
4 |
S |
$36.74 |
$562,019 |
D/D |
(15,298) |
98,884 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Pres, Eur, Mid-East, Afr |
• • – |
2021-08-10 |
4 |
OE |
$13.08 |
$261,600 |
D/D |
20,000 |
86,129 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Pres, Eur, Mid-East, Afr |
• • – |
2024-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
37,776 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Eur, Mid-East, Afr |
• • – |
2018-05-17 |
4 |
S |
$30.15 |
$603,368 |
D/D |
(20,015) |
112,859 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Eur, Mid-East, Afr |
• • – |
2019-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
20,278 |
130,868 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Pres, Eur, Mid-East, Afr |
• • – |
2022-08-01 |
4 |
S |
$40.99 |
$847,509 |
D/D |
(20,676) |
72,486 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Eur, Mid-East, Afr |
• • – |
2019-05-29 |
4 |
S |
$38.03 |
$838,432 |
D/D |
(22,047) |
88,978 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Eur, Mid-East, Afr |
• • – |
2018-11-09 |
4 |
OE |
$8.30 |
$194,701 |
D/D |
23,458 |
137,640 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Eur, Mid-East, Afr |
• • – |
2018-11-09 |
4 |
S |
$37.51 |
$879,886 |
D/D |
(23,458) |
114,182 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
SVP & Pres, Europe |
• • – |
2017-02-06 |
4 |
S |
$24.94 |
$592,858 |
D/D |
(23,775) |
98,458 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Pres, Eur, Mid-East, Afr |
• • – |
2021-02-12 |
4 |
AS |
$38.65 |
$1,116,354 |
D/D |
(28,883) |
71,200 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
EVP & Pres, Eur, Mid-East, Afr |
• • – |
2023-05-02 |
4 |
OE |
$12.89 |
$395,568 |
D/D |
30,688 |
95,670 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Pres, Eur, Mid-East, Afr |
• • – |
2021-02-17 |
4 |
OE |
$7.47 |
$241,677 |
D/D |
32,353 |
104,399 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Pres, Eur, Mid-East, Afr |
• • – |
2021-08-05 |
4 |
S |
$44.14 |
$1,842,306 |
D/D |
(41,741) |
66,129 |
0 |
% |
|
151 Records found
|
|
Page 6 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
